These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

845 related articles for article (PubMed ID: 18251359)

  • 41. Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment--recombinant HCG versus urinary HCG. The European Recombinant Human Chorionic Gonadotrophin Study Group.
    Hum Reprod; 2000 Jul; 15(7):1446-51. PubMed ID: 10875887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intrauterine insemination with recombinant or urinary human chorionic gonadotropin: A prospective randomized trial.
    Lorusso F; Palmisano M; Serratì G; Bassi E; Lamanna G; Vacca M; Depalo R
    Gynecol Endocrinol; 2008 Nov; 24(11):644-8. PubMed ID: 19031222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study.
    Kol S; Humaidan P; Itskovitz-Eldor J
    Hum Reprod; 2011 Oct; 26(10):2874-7. PubMed ID: 21784738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates.
    Acevedo B; Gomez-Palomares JL; Ricciarelli E; Hernández ER
    Fertil Steril; 2006 Dec; 86(6):1682-7. PubMed ID: 17074344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GnRHa to trigger final oocyte maturation: a time to reconsider.
    Humaidan P; Papanikolaou EG; Tarlatzis BC
    Hum Reprod; 2009 Oct; 24(10):2389-94. PubMed ID: 19608565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro.
    Bramley TA; Stirling D; Menzies GS; Baird DT
    Reproduction; 2005 Jan; 129(1):61-73. PubMed ID: 15615899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum and follicular endocrine profile is different in modified natural cycles than in cycles stimulated with gonadotropin and gonadotropin-releasing hormone antagonist.
    Jancar N; Virant-Klun I; Bokal EV
    Fertil Steril; 2009 Dec; 92(6):2069-71. PubMed ID: 19815198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
    Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
    Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
    Ellenbogen A; David H; Libal Y; Ballas S
    Harefuah; 1995 Dec; 129(11):455-6, 536. PubMed ID: 8846950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
    Barad DH; Weghofer A; Gleicher N
    Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination.
    Duffy DA; Manzi D; Benadiva C; Maier D; Saunders M; Nulsen J
    Fertil Steril; 2006 Feb; 85(2):407-11. PubMed ID: 16595219
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low-dose human chorionic gonadotropin versus estradiol/progesterone luteal phase support in gonadotropin-releasing hormone agonist-triggered assisted reproductive technique cycles: understanding a new approach.
    Garcia-Velasco JA; Motta L; López A; Mayoral M; Cerrillo M; Pacheco A
    Fertil Steril; 2010 Dec; 94(7):2820-3. PubMed ID: 20673892
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The prevalence and influence of luteinizing hormone surges in stimulated cycles combined with intrauterine insemination during a prospective cohort study.
    Cantineau AE; Cohlen BJ;
    Fertil Steril; 2007 Jul; 88(1):107-12. PubMed ID: 17445811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attempt to control the day of ovulation in cycling pony mares by associating a GnRH antagonist with hCG.
    Briant C; Ottogalli M; Guillaume D
    Domest Anim Endocrinol; 2004 Aug; 27(2):165-78. PubMed ID: 15219935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated day 3 follicle-stimulating hormone in younger women: is gonadotropin stimulation/intrauterine insemination a good option?
    Souter I; Dimitriadis I; Baltagi LM; Meeker JD; Petrozza JC
    Am J Obstet Gynecol; 2014 Jul; 211(1):62.e1-8. PubMed ID: 24487006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of serum progesterone and LH values on the day of hCG administration in IUI GnRH antagonist cycles.
    Matorras R; Soler AV; Ramon O; Burgos J; Abanto E; González M; Múgica J; Corcóstegui B; Pijoan JI; Exposito A
    Gynecol Endocrinol; 2012 Mar; 28(3):157-61. PubMed ID: 21801119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gonadotropin Releasing Hormone Agonist Final Oocyte Maturation and Human Chorionic Gonadotropin as Exclusive Luteal Support in Normal Responders.
    Beck-Fruchter R; Baram S; Geslevich Y; Weiss A
    Gynecol Obstet Invest; 2019; 84(1):27-34. PubMed ID: 30048969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hormonal characteristics in the early luteal phase of conceptive and nonconceptive menstrual cycles.
    Chen J; Qiu Q; Lohstroh PN; Overstreet JW; Lasley BL
    J Soc Gynecol Investig; 2003 Jan; 10(1):27-31. PubMed ID: 12517590
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gonadotropin-releasing hormone agonist or human chorionic gonadotropin for final oocyte maturation in an oocyte donor program.
    Erb TM; Vitek W; Wakim AN
    Fertil Steril; 2010 Feb; 93(2):374-8. PubMed ID: 19171336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.